Zynerba Pharmaceuticals, Inc. 4
4 · Zynerba Pharmaceuticals, Inc. · Filed Jan 26, 2017
Insider Transaction Report
Form 4
Hanlon Suzanne M.
General Counsel
Transactions
- Award
Stock Option (right to buy)
2017-01-25+60,000→ 60,000 totalExercise: $18.22Exp: 2027-01-25→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The stock option vests 25% on the first anniversary of the date of the grant, with the remainder vesting in 12 equal quarterly installments thereafter, subject to continued employment with the Company.